Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Subclinical involvement of the liver is associated with prognosis in treatment naïve cancer patients.
Pavo N, Raderer M, Goliasch G, Wurm R, Strunk G, Cho A, Novak JF, Gisslinger H, Steger GG, Hejna M, Köstler W, Zöchbauer-Müller S, Marosi C, Kornek G, Auerbach L, Schneider ST, Parschalk B, Scheithauer W, Pirker R, Kiesewetter B, Pacher R, Zielinski C, Hülsmann M. Pavo N, et al. Among authors: steger gg. Oncotarget. 2017 Apr 16;8(46):81250-81260. doi: 10.18632/oncotarget.17131. eCollection 2017 Oct 6. Oncotarget. 2017. PMID: 29113384 Free PMC article.
Monitoring of serum Her-2/neu predicts response and progression-free survival to trastuzumab-based treatment in patients with metastatic breast cancer.
Köstler WJ, Schwab B, Singer CF, Neumann R, Rücklinger E, Brodowicz T, Tomek S, Niedermayr M, Hejna M, Steger GG, Krainer M, Wiltschke C, Zielinski CC. Köstler WJ, et al. Among authors: steger gg. Clin Cancer Res. 2004 Mar 1;10(5):1618-24. doi: 10.1158/1078-0432.ccr-0385-3. Clin Cancer Res. 2004. PMID: 15014012
The efficacy of trastuzumab in Her-2/neu-overexpressing metastatic breast cancer is independent of p53 status.
Köstler WJ, Brodowicz T, Hudelist G, Rudas M, Horvat R, Steger GG, Singer CF, Attems J, Rabitsch W, Fakhrai N, Elandt K, Wiltschke C, Hejna M, Zielinski CC. Köstler WJ, et al. Among authors: steger gg. J Cancer Res Clin Oncol. 2005 Jul;131(7):420-8. doi: 10.1007/s00432-005-0670-3. Epub 2005 Apr 29. J Cancer Res Clin Oncol. 2005. PMID: 15864644
[The use of erythropoiesis-stimulating proteins in anemic patients with malignant diseases].
Osterreichische Konsensus-Gruppe zum Einsatz von Erythropoese-stimulierenden Proteinen bei Chemotherapie-induzierter Anämie, unter der Schirmherrschaft der OGHO; Ludwig H, Auberger T, Burghuber OCh, Gnant M, Hopfinger G, Jäger U, Keil F, Kornek G, Linkesch W, Petru E, Pirker R, Pittermann E, Reinthaller A, Samonigg H, Steger G, Stockenhuber F, Studnicka M, Weiss G, Zielinski C. Osterreichische Konsensus-Gruppe zum Einsatz von Erythropoese-stimulierenden Proteinen bei Chemotherapie-induzierter Anämie, unter der Schirmherrschaft der OGHO, et al. Wien Klin Wochenschr. 2008;120(15-16):507-13. doi: 10.1007/s00508-008-1007-4. Wien Klin Wochenschr. 2008. PMID: 18820857 German. No abstract available.
Indocyanine green video angiography predicts outcome of extravasation injuries.
Haslik W, Pluschnig U, Steger GG, Zielinski CC, Schrögendorfer KF, Nedomansky J, Bartsch R, Mader RM. Haslik W, et al. Among authors: steger gg. PLoS One. 2014 Aug 21;9(8):e103649. doi: 10.1371/journal.pone.0103649. eCollection 2014. PLoS One. 2014. PMID: 25144707 Free PMC article.
227 results